We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lugol's Solution Stabilized with PVP for Gram Stain

By LabMedica International staff writers
Posted on 03 Jan 2011
Print article
Lugol's solution is an aqueous solution, which contains iodine (I2) and potassium iodide (KI) in a ratio of 1:2.

Used for Gram staining, Lugol's iodine solution is required to form the dye-iodine complex of Gram-positive bacteria. It can also be used as an antiseptic and disinfectant for emergency disinfection of drinking water, and as a reagent for starch detection in routine laboratory and other medical tests.

Stock solutions of I2 - KI in water are unstable. Iodine can be lost by evaporation and that can influence the result of the staining as well as affecting the working conditions in that area. Stainless steel parts of staining instruments can also be affected by the iodine in the Lugol's solution. If the concentration of iodine in the Lugol's solution decreases, the bacterial smears may become more susceptible to decolorization.

The problem of iodine loss can be overcome by using polyvinylpyrrolidine (PVP) in the I2 - KI solution. PVP forms a complex with iodine. This complex is more stable and has a longer shelf life. Material treated with Lugol's solution stabilized with PVP will give identical results with regard to differentiation of Gram-positive and Gram-negative bacteria compared to the standard Lugol's solution.

In the standard Gram procedure, the aniline dyes in the cell tissue of microorganisms form a red dye-iodine complex when exposed to iodine. In Gram-positive microorganisms, the dye-iodine complex cannot subsequently be dissolved from the cells by decolorizing agents such as alcohol or acetone. The cells remain dark blue in color. In Gram-negative microorganisms, the dye-iodine complex is dissolved and the cell turns red as a result of counterstaining.

Both Lugol's solutions (the standard type and the stabilized type) are available for bacteriological staining from Merck KGaA (Darmstadt, Germany), or EMD Chemicals (Gibbstown, NJ, USA) in the USA. Suitable protocols are available on the internet or on demand.

Related Links:
Merck KGaA
EMD Chemicals



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Pipet Controller
Stripettor Pro

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.